Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Thromboprophylaxis × apixaban × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Venous Thromboembolism 14 Neoplasms 10 Venous Thrombosis 7 Pulmonary Embolism 7 Multiple Myeloma 4 Thrombosis 3 Upper Extremity Deep Vein Thrombosis 2 Pancreatic Neoplasms 2 Neoplasm Metastasis 2 Myeloproliferative Disorders 2 Intracranial Thrombosis 2 Hematologic Neoplasms 2 Carcinoma, Hepatocellular 2 Urinary Bladder Neoplasms 1 Thromboprophylaxis 1 Thromboembolism 1 Thrombocytopenia 1 Thrombocythemia, Essential 1 Stomach Neoplasms 1 Primary Myelofibrosis 1 Polycythemia Vera 1 Neoplasms, Plasma Cell 1 Mesenteric Ischemia 1 Lymphoma 1 Leukemia 1 Gastrointestinal Stromal Tumors 1 Gallbladder Neoplasms 1 Fibrosis 1 Esophageal Neoplasms 1 Duodenal Neoplasms 1

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07160686 2025-09-08

THROMBO-STOP

University of Birmingham

Phase 3 Not yet recruiting

Thromboprophylaxis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡